Post-discharge growth, body composition and neurodevelopment outcome of very preterm infants in relation to two formulas with different composition in terms of energy and protein content
ISRCTN | ISRCTN30189842 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN30189842 |
Secondary identifying numbers | N/A |
- Submission date
- 15/07/2009
- Registration date
- 04/09/2009
- Last edited
- 17/04/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Paola Roggero
Scientific
Scientific
Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli Regina Elena
University Medical School of Milan
Via Commenda 12
Milan
20122
Italy
Study information
Study design | Single centre randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Post-hospital discharge feeding for very preterm infants: effects of standard compared with enriched milk formula on growth, body composition and neurodevelopment outcome - a single centre randomised controlled trial |
Study objectives | The goal is to evaluate the effects on post-discharge growth, body composition and neurodevelopment outcome of two distinct strategies for post-discharge nutrition. |
Ethics approval(s) | Ethical Committee FONDAZIONE IRCCS Ospedale Maggiore Policlinico Mangiagalli Regina Elena approved on the 7th July 2009 |
Health condition(s) or problem(s) studied | Pre-term infant post-discharge nutrition and body composition |
Intervention | Infants will be enrolled at term equivalent age and will be prospectively followed-up from term to 12 months of corrected age. At term equivalent age infants will be randomised in four groups: Group 1: infants born average for gestational age (AGA) fed nutrient-enriched post-discharge formula (2.2 g/100 ml; 75 kcal/100 ml) Group 2: infants born AGA fed standard formula (1.4 g/100 ml; 67 kcal/100 ml) Group 3: infants born small for gestational age (SGA) fed nutrient-enriched post-discharge formula (2.2 g/100 ml; 75 kcal/100 ml) Group 4: infants born SGA fed standard formula (1.4 g/100 ml; 67 kcal/100 ml) From term up to the six month, infants will be fed a nutrient-enriched post-discharge or standard formula (according to randomisation) on demand and will be given no other foods. Parents will be instructed to record the daily quantities of milk consumed by the infants in a diary. The average daily energy and protein intakes (expressed as kcal/kg body weight/d and g/kg body weight/d, respectively) will be calculated at each study visit time. Infants will enter a follow-up program that consists of assessment of periodic growth and body composition assessments (by means of an air displacement plethysmography system and the four skinfold thicknesses [triceps, biceps, subscapular and suprailiac], with use of a skinfold calliper) at term corrected age, 15 d, 1, 3, 5, 6 and 12 months of corrected age. Neurodevelopmental outcome will be also assessed by means of a neurofunctional evaluation (at 40 weeks, 3, 6, 12 months' corrected age) and the Griffith Scale (at 12 months of corrected age). Reference group: The reference group will be represented by infants fed human milk who will not be randomised but will undergo the growth, body composition and neurodevelopment assessment according to the protocol. In order to detect a 5% difference in fat mass among groups at a significance level of 0.05 and 80% power, 40 infants are needed for each group. Taking into account lost-to-follow up/withdrawal, a total number of 160 will need to be recruited for the study. Taking into account lost-to-follow up/withdrawal, a total number of 184 will need to be recruited for the study. |
Intervention type | Other |
Primary outcome measure | 1. Body composition (assessed by means of an air plethismography-Pea Pod and the four skinfold thicknesses [triceps, biceps, subscapular and suprailiac] with use of a skinfold calliper), at term corrected age, 15 d, 1, 3, 5, 6 and 12 months of corrected age 2. Growth (weight, length and head circumference assessed at term corrected age, 15 d, 1, 3, 5, 6 and 12 months of corrected age) |
Secondary outcome measures | Neurodevelopment outcome (by means of a neurofunctional evaluation at 40 weeks, 3, 6, 12 months' corrected age) and the Griffith Scale (at 12 months of corrected age). |
Overall study start date | 15/09/2009 |
Completion date | 15/09/2013 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Neonate |
Sex | Both |
Target number of participants | 184 |
Key inclusion criteria | 1. Birth weight less than 1500 g 2. Gestational age less than 33 weeks 3. Caucasian race, either sex 4. Informed consent signed by infants' parents or legal guardian |
Key exclusion criteria | 1. Congenital diseases 2. Chromosomal abnormalities 3. Severe gastrointestinal diseases (i.e. necrotising enterocolitis) 3. Metabolic and or endocrine disease 4. Severe brain injury 5. Chronic lung disease |
Date of first enrolment | 15/09/2009 |
Date of final enrolment | 15/09/2013 |
Locations
Countries of recruitment
- Italy
Study participating centre
Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli Regina Elena
Milan
20122
Italy
20122
Italy
Sponsor information
Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli Regina Elena (Italy)
Research organisation
Research organisation
Dipartimento di Scienze Materno-Infantili
Via Commenda 12
Milan
20122
Italy
Website | http://www.mangiagalli.it |
---|---|
https://ror.org/016zn0y21 |
Funders
Funder type
Research organisation
Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli Regina Elena (Italy)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/11/2012 | Yes | No | |
Results article | results | 19/03/2014 | Yes | No |